| Type : |
Journal |
|
| Forskerteamet : |
Callaghan - School of Pharmacy and Medical Sciences |
| Forfattere : |
Sharley NA, Yu AMC, Williams DB. |
| Tittel : |
Stability of mixtures formulated from warfarin tablets or powder. |
| Nummer : |
J Pharm Pract and Res ; 37: 95-97. 2007 |
|
| Nivå of Evidence : |
|
| fysisk stabilitet : |
|
| kjemisk stabilitet : |
|
| andre metoder : |
|
| Kommentarer : |
|
Lister
 Warfarin sodium
|
 |
 |
 |
 |
300 mg
Coumadin® |
| Natriumfosfat |
3000 mg |
| Tragant |
4% 60 ml |
| Sorbitolsirup |
5% 75 ml |
| Metylparaben |
240 mg |
| Propylparaben |
60 mg |
| Propylenglykol |
3 ml |
| Destillert vann |
>> 300 ml |
|
20-24°C |
 |
| 28 |
 |
|
|
|
|
|
300 mg
Marevan® |
| Natriumfosfat |
3000 mg |
| Tragant |
4% 60 ml |
| Sorbitolsirup |
5% 75 ml |
| Metylparaben |
240 mg |
| Propylparaben |
60 mg |
| Propylenglykol |
3 ml |
| Destillert vann |
>> 300 ml |
|
20-24°C |
|
| 28 |
|
|
|
|
|
Warfarin sodium clathrate
|
|
|
|
 |
324.3 mg
Warfarin sodium clathrate |
| Natriumfosfat |
3000 mg |
| Metylparaben |
240 mg |
| Propylparaben |
60 mg |
| Propylenglykol |
3 ml |
| Destillert vann |
>> 300 ml |
|
20-24°C |
|
| 28 |
|
|
|
|
|
